Amneal Pharmaceuticals Balance Sheet
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Amneal Pharmaceuticals financial position
At the end of fiscal 2025, Amneal Pharmaceuticals reported total assets of $3.68 billion, up 5.1% from a year earlier against total liabilities of $3.75 billion. Shareholders' equity was negative at -$70.8 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $282.0 million in cash and equivalents against $2.57 billion of debt, a net debt position of $2.29 billion.
The current ratio (current assets divided by current liabilities) was 2.17, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Amneal Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 282.03M | 110.55M | 91.54M | 25.98M | 247.79M | 341.38M | 151.20M | 213.39M | 74.17M | 27.37M |
| Receivables | — | — | — | 741.79M | 662.58M | 638.89M | 604.39M | 481.50M | 351.37M | — |
| Inventory | 606.30M | 612.45M | 581.38M | 530.74M | 489.39M | 490.65M | 381.07M | 457.22M | 284.04M | — |
| Total Current Assets | 1.91B | 1.59B | 1.38B | 1.41B | 1.52B | 1.55B | 1.21B | 1.29B | 771.93M | — |
| Property, Plant & Equipment | 442.95M | 424.91M | 447.57M | 469.81M | 514.16M | 477.75M | 478.00M | 544.15M | 486.76M | — |
| Goodwill | 595.47M | 597.44M | 598.63M | 598.85M | 593.02M | 522.81M | 419.50M | 426.23M | 26.44M | 28.44M |
| Intangible Assets | 563.50M | 732.38M | 890.42M | 1.10B | 1.17B | 1.30B | 1.38B | 1.65B | 44.60M | — |
| Total Assets | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B | 4.01B | 3.67B | 4.35B | 1.34B | — |
| Accounts Payable | — | 258.69M | 143.57M | 165.98M | 131.08M | 153.14M | 103.02M | 114.85M | 70.01M | — |
| Short-Term Debt | 6.76M | 224.21M | 34.13M | 29.96M | 30.61M | 44.23M | 21.48M | 21.45M | 89.17M | — |
| Total Current Liabilities | 881.63M | 1.13B | 846.60M | 752.80M | 677.24M | 676.90M | 550.41M | 553.85M | 296.88M | — |
| Long-Term Debt | 2.57B | 2.16B | 2.39B | 2.59B | 2.68B | 2.74B | 2.61B | 2.63B | 1.36B | — |
| Total Liabilities | 3.75B | 3.61B | 3.45B | 3.62B | 3.57B | 3.66B | 3.32B | 3.46B | 0 | — |
| Shareholders' Equity | -70.79M | -109.27M | 19.78M | 298.42M | 360.34M | 303.27M | 232.01M | 504.75M | 0 | — |
| Retained Earnings | -535.00M | -607.06M | -490.18M | -406.18M | -276.20M | -286.82M | -377.88M | -20.92M | -382.79M | — |
| Total Debt | 2.57B | 2.39B | 2.42B | 2.62B | 2.71B | 2.78B | 2.63B | 2.65B | 1.44B | — |
| Net Cash (Debt) | -2.29B | -2.28B | -2.33B | -2.60B | -2.46B | -2.44B | -2.48B | -2.44B | -1.37B | 27.37M |
| Shares Outstanding | — | — | — | — | — | — | — | — | 1.00K | — |
This table shows 10 annual periods of Amneal Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow AMRX's reporting calendar. What is a balance sheet?